Dr. Muralidhar Beeram, M.D.
What this data tells you about Dr. Beeram
Dr. Muralidhar Beeram is a medical oncology specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Beeram performed 11,750 Medicare services across 1,941 unique beneficiaries.
Between the years covered by Open Payments, Dr. Beeram received a total of $107,662 from 76 pharmaceutical and/or device companies across 690 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Beeram is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,900 | $18 | $71 |
| Dexamethasone injection (steroid) | 1,434 | $0 | $0 |
| Injection, potassium chloride, per 2 meq | 940 | $0 | $0 |
| Comprehensive metabolic blood panel | 701 | $10 | $32 |
| Complete blood count (CBC) with differential | 656 | $8 | $23 |
| Injection, magnesium sulfate, per 500 mg | 462 | $1 | $2 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 406 | $22 | $86 |
| Blood draw (venipuncture) | 380 | $8 | $16 |
| Office visit, established patient (30-39 min) | 375 | $94 | $373 |
| Administration of chemotherapy into vein, 1 hour or less | 317 | $100 | $377 |
| Office visit, established patient, complex (40-54 min) | 291 | $133 | $523 |
| Injection, zoledronic acid, 1 mg | 145 | $6 | $69 |
| Injection of additional new drug or substance into vein | 140 | $12 | $58 |
| Magnesium level test | 129 | $7 | $20 |
| Administration of additional new drug or substance into vein, 1 hour or less | 122 | $50 | $205 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 109 | $358 | $1,365 |
| Lactate dehydrogenase (enzyme) level | 104 | $6 | $18 |
| Iron level test | 96 | $6 | $19 |
| Iron binding capacity test | 96 | $9 | $26 |
| Drug injection, under skin or into muscle | 96 | $11 | $47 |
| Injection, diphenhydramine hcl, up to 50 mg | 95 | $1 | $3 |
| Ferritin level test (iron stores) | 93 | $13 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 91 | $48 | $185 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 82 | $16 | $60 |
| Administration of chemotherapy into vein, each additional hour | 69 | $22 | $90 |
| Infusion into a vein for hydration, each additional hour | 64 | $10 | $42 |
| New patient office visit, complex (60-74 min) | 47 | $172 | $641 |
| Vitamin B-12 level test | 46 | $15 | $45 |
| Complete blood count (CBC), automated | 44 | $6 | $19 |
| Infusion, normal saline solution , 1000 cc | 43 | $2 | $19 |
| Hospital follow-up visit, moderate complexity | 36 | $62 | $232 |
| Infusion into a vein for hydration, 31-60 minutes | 35 | $25 | $137 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 34 | $20 | $62 |
| Office visit, established patient (20-29 min) | 33 | $65 | $271 |
| Immunoglobulin level test | 20 | $9 | $28 |
| Uric acid level test | 19 | $4 | $14 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Beeram is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 13% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Beeram experienced with denosumab injection (prolia/xgeva)?
Does Dr. Beeram receive payments from pharmaceutical companies?
How do Dr. Beeram's costs compare to other medical oncologists in San Antonio?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology